SBIR/STTR Research Award
Optohydraulic Biotransport Sensor
Award amount
$105,948Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- C AND L INSTRUMENTS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Diabetic retinopathy, the leading cause of blindness among working-age
Americans, is characterized by increased retinal microvascular permeability
which results in the formation of lipid exudates, macular edema and blindness.
Recent data suggest that water and solutes cross the blood-retinal barrier
through separate and differentially regulated transport pathways. To date, the
only systems available to study changes in permeability are based on transit
measurement of non-specific ion permeability or the accumulation of labeled
solutes. To better investigate the basis of these pathways, we developed a
prototype instrument to determine transport rates of water and solute flux
across cell monolayers in realtime and under a variety of physiologic
conditions. Water flux is measured by tracking an air bubble hydraulically
coupled to a cell culture chamber. Solute flux is measured by monitoring flux
of a fluorescent-labeled protein. Computer-controlled filter wheels, combined
with gating and multiplexing techniques are used to monitor up to four solutes
in two or more separate cell chambers simultaneously. Cells are cultured in
plastic transwetl fitters and are then placed in the cell chamber. Opticat
fibers and tubing are used to couple the cell chambers to the main instrument.
The chambers can be placed either on a bench top or in a cell incubator for
climate control. Our optohydraulic instrument enables investigators to easily
monitor and compare water and solute transport properties of cell monolayers in
response to various vasoactive substances. Furthermore, the ability to measure
both of these parameters in the same preparation allows analysis of previously
unobtainable data for study of cellular permeability. We anticipate that this
instrument will significantly advance the study of vascular permeability and
facilitate developments in pharmacotherapy.
PROPOSED COMMERCIAL APPLICATION:
This is a novel instrument that has a high potential for commercialization. The control of
vascular permeability is a research area that is being aggressivly studied by scientists
in academia and the private sector. No other instruments of its type exist.
Technology keywords
Not reported